We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Low Testosterone Could Peril Heart

By HospiMedica staff writers
Posted on 23 Jul 2007
Post-menopausal women with low levels of the male sex hormone testosterone are more likely to develop heart disease, a new study suggests. More...


Researchers at the Free University of Brussels (Belgium) examined the levels of sex hormones in natural post-menopausal women--women not taking hormone replacement therapy--and their association with the presence of atherosclerosis. The research team examined 56 post-menopausal women who had atherosclerosis of the internal carotid artery (ICA) and who were referred for carotid artery endarterectomy (CEA) and compared the levels of sex hormones in their blood with 56 age-matched controls.

While the researchers found no significant difference between the levels of other sex hormones, women with atherosclerosis had significantly lower testosterone levels than women who were free from the disease. Even after the researchers controlled for other risk factors associated with heart disease (such as diet, high blood pressure, smoking, and diabetes), the relationship between low testosterone levels and atherosclerosis remained strong. The researchers concluded that, that higher, but physiologic, levels of androgens in postmenopausal women have a protective role in the development of atherosclerosis of the ICA. The study was published in the June 2007 issue of the European Journal of Endocrinology.

"Our work suggests that higher levels of testosterone may have a protective role against atherosclerosis in women who have undergone the menopause,” said lead author Dr. Erik Debing, from the department of vascular surgery. "This research represents an important step forward in our understanding of the causes of atherosclerosis and will allow us to develop more effective treatments and advice.”

Atherosclerosis is a condition where the arteries become hardened and blocked by the deposition of substances such as cholesterol, and is commonly seen as a precursor to heart disease.


Related Links:
Free University of Brussels

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.